Emerging and re-emerging infectious disease in otorhinolaryngology (ENT) are an area of growing epidemiological and clinical interest. The aim of this section is to comprehensively report on the epidemiology of key infectious disease in otorhinolaryngology, reporting on their burden at the national and international level, expanding of the need of promoting and implementing preventive interventions, and the rationale of applying evidence-based, effective and cost- effective diagnostic, curative and preventive approaches. In particular, we focus on i) ENT viral infections (HIV, Epstein-Barr virus, Human Papilloma virus), retrieving the available evidence on their oncogenic potential; ii) typical and atypical mycobacteria infections; iii) non-specific granulomatous lymphadenopathy; iv) emerging paediatric ENT infectious diseases and the prevention of their complications; v) the growing burden of antimicrobial resistance in ENT and the strategies for its control in different clinical settings. We conclude by outlining knowledge gaps and action needed in ENT infectious diseases research and clinical practice and we make references to economic analysis in the field of ENT infectious diseases prevention and care.

Emerging and re-emerging infectious disease in otorhinolaryngology [Patologia infettiva emergente e riemergente in otorinolaringoiatria]

Ferrari, G.;Cocuzza, S.
Membro del Collaboration Group
;
Conti, B.;di Mauro, P.
Membro del Collaboration Group
;
Giuliani, M.;Maiolino, L.
Membro del Collaboration Group
;
Marini, G.;Palma, S.;Serra, A.
Writing – Original Draft Preparation
;
Signorelli, C.;
2018-01-01

Abstract

Emerging and re-emerging infectious disease in otorhinolaryngology (ENT) are an area of growing epidemiological and clinical interest. The aim of this section is to comprehensively report on the epidemiology of key infectious disease in otorhinolaryngology, reporting on their burden at the national and international level, expanding of the need of promoting and implementing preventive interventions, and the rationale of applying evidence-based, effective and cost- effective diagnostic, curative and preventive approaches. In particular, we focus on i) ENT viral infections (HIV, Epstein-Barr virus, Human Papilloma virus), retrieving the available evidence on their oncogenic potential; ii) typical and atypical mycobacteria infections; iii) non-specific granulomatous lymphadenopathy; iv) emerging paediatric ENT infectious diseases and the prevention of their complications; v) the growing burden of antimicrobial resistance in ENT and the strategies for its control in different clinical settings. We conclude by outlining knowledge gaps and action needed in ENT infectious diseases research and clinical practice and we make references to economic analysis in the field of ENT infectious diseases prevention and care.
2018
Bacterial resistance; EBV; HIV; HPV; Mycobacteriosis; Nanomedicine; Otorhinolaryngology2734 Pathology and Forensic Medicine
File in questo prodotto:
File Dimensione Formato  
EMERGIN AND RE-EMERGING INFECTIOUS DISEASE IN OTORHINOLARYNGOLOGY.pdf

accesso aperto

Descrizione: ARTICOLO PRINCIPALE
Tipologia: Versione Editoriale (PDF)
Dimensione 5.05 MB
Formato Adobe PDF
5.05 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11769/333060
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 4
social impact